Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Campone, Mario"'
Autor:
Någård M; Clinical Pharmacology and Quantitative Pharmacology, R&D Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD, USA., Ah-See ML; Late Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK., So K; Late Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK., Vermunt M; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Thistlethwaite F; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., Labots M; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Roxburgh P; Beaston West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK., Ravaud A; Bordeaux University Hospital, Bordeaux, France., Campone M; ICO - Site René, Saint Herblain, France., Valkenburg-van Iersel L; Maastricht University Medical Centre, Maastricht, The Netherlands., Ottesen L; Late Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK., Li Y; Clinical Pharmacology Biologics and Bioanalysis, Clinical Pharmacology and Safety Science, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA., Mugundu G; Clinical Pharmacology and Quantitative Pharmacology, R&D Clinical Pharmacology and Safety Sciences, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA. ganesh.mugundu@astrazeneca.com.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Jul; Vol. 86 (1), pp. 97-108. Date of Electronic Publication: 2020 Jun 16.
Autor:
Rosenbaum P; Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, 28 rue du Dr Roux, 75015, Paris, France.; INSERM U1041, 75015, Paris, France., Artaud C; Institut Pasteur, Centre de Recherche Translationnelle-Coordination Clinique, 75015, Paris, France., Bay S; Institut Pasteur, Unité de Chimie des Biomolécules, 75015, Paris, France.; Centre National de la Recherche Scientifique UMR3523, 75015, Paris, France., Ganneau C; Institut Pasteur, Unité de Chimie des Biomolécules, 75015, Paris, France.; Centre National de la Recherche Scientifique UMR3523, 75015, Paris, France., Campone M; Institut de Cancérologie de l'Ouest, Saint-Herblain, 44800, Nantes, France., Delaloge S; Institut Gustave Roussy, 94800, Villejuif, France., Gourmelon C; Institut de Cancérologie de l'Ouest, Saint-Herblain, 44800, Nantes, France., Loirat D; Département d'Oncologie Médicale, Institut Curie, 75015, Paris, France., Medioni J; Assistance Publique-Hôpitaux de Paris (AP-HP), Centre d'Essais Précoces en Cancérologie, Hôpital Européen Georges-Pompidou, Faculté de Médecine Paris Descartes, 75015, Paris, France., Pein F; Institut de Cancérologie de l'Ouest, Saint-Herblain, 44800, Nantes, France., Sablin MP; Département d'Oncologie Médicale, Institut Curie, 75015, Paris, France., Tredan O; Medical Oncology Department, Centre Léon Bérard, 69008, Lyon, France., Varga A; Institut Gustave Roussy, 94800, Villejuif, France., Leclerc C; Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, 28 rue du Dr Roux, 75015, Paris, France. claude.leclerc@pasteur.fr.; INSERM U1041, 75015, Paris, France. claude.leclerc@pasteur.fr.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 May; Vol. 69 (5), pp. 703-716. Date of Electronic Publication: 2020 Feb 07.
Autor:
Martin N; Institut Universitaire du Cancer de Toulouse, Oncopôle, 1 avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France., Isambert N; Centre Georges-François Leclerc, 1 rue Professeur Marion BP 77980, 21079, Dijon Cedex, France., Gomez-Roca C; Institut Universitaire du Cancer de Toulouse, Oncopôle, 1 avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France., Goeldner RG; Boehringer Ingelheim Pharma GmbH and Co. KG, Global BDS, Birkendorfer Strasse 65, 88397, Biberach an der Riss, Germany., Zanetta S; Centre Georges-François Leclerc, 1 rue Professeur Marion BP 77980, 21079, Dijon Cedex, France., Sadrolhefazi B; Boehringer Ingelheim (Canada) Ltd./Ltee, 5180 South Service Road, Burlington, ON, L7L 5H4, Canada., de Mont-Serrat H; Boerhinger Ingelheim (France), 12, rue André Huet, 51100, Reims, France., Campone M; Institut de Cancérologie de L'Ouest site CLCC René Gauducheau, Boulevard Jacques Monod, 44805, Saint-Herblain Cedex, France., Delord JP; Institut Universitaire du Cancer de Toulouse, Oncopôle, 1 avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France. delord.jean-pierre@iuct-oncopole.fr.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2018 Dec; Vol. 82 (6), pp. 979-986. Date of Electronic Publication: 2018 Oct 22.
Autor:
Imbs DC; Institut Claudius-Regaud, IUCT-O, Toulouse, France.; EA4553, Université Paul-Sabatier, Toulouse, France., Diéras V; Department of Medical Oncology, Institut Curie, Paris, France., Bachelot T; Department of Medical Oncology, Centre Léon-Bérard, Lyon, France., Campone M; Centre de Recherche du Cancer Nantes-Angers, UMR-INSERM U892/CNRS 6299, Institut de Cancérologie de l'Ouest, Nantes, France., Isambert N; Department of Medical Oncology, Centre Georges François-Leclerc, Dijon, France., Joly F; Department of Medical Oncology, Centre François-Baclesse, Caen, France., Jimenez M; Unicancer, Paris, France. m-jimenez@unicancer.fr., Lafont T; Institut Claudius-Regaud, IUCT-O, Toulouse, France.; EA4553, Université Paul-Sabatier, Toulouse, France., Chatelut E; Institut Claudius-Regaud, IUCT-O, Toulouse, France. chatelut.etienne@iuct-oncopole.fr.; EA4553, Université Paul-Sabatier, Toulouse, France. chatelut.etienne@iuct-oncopole.fr.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Feb; Vol. 77 (2), pp. 385-92. Date of Electronic Publication: 2016 Jan 16.
Autor:
Plummer R; Northern Centre for Cancer Care, Newcastle upon Tyne, NE7 7DN, UK., Stephens P, Aissat-Daudigny L, Cambois A, Moachon G, Brown PD, Campone M
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2014 Aug; Vol. 74 (2), pp. 257-65. Date of Electronic Publication: 2014 Jun 01.
Autor:
Campone M; Centre René Gauducheau, Service Oncologie Médicale, Boulevard Jacques Monod, 44805, Nantes Saint-Herblain, France. m-campone@nantes.fnclcc.fr, Blasinska-Morawiec M, Tekiela A, Koralewski P, Pouget JC, Douville I, Brandely M
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2009 Apr; Vol. 63 (5), pp. 937-43. Date of Electronic Publication: 2008 Aug 27.
Autor:
Campone M; Centre René Gauducheau, Nantes, France., Rademaker-Lakhai JM, Bennouna J, Howell SB, Nowotnik DP, Beijnen JH, Schellens JH
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2007 Sep; Vol. 60 (4), pp. 523-33. Date of Electronic Publication: 2007 Feb 17.